Ovarian Cancer Translational Activity of the Multicenter Italian Trial in Ovarian Cancer (MITO) Group: Lessons Learned in 10 Years of Experience

Ovarian cancer is the most lethal gynecological cancer, and despite years of research, with the exception of a BRCA mutation driving the use of PARP inhibitors, no new prognostic/predictive biomarkers are clinically available. Improvement in biomarker selection and validation may derive from the sys...

Descripción completa

Detalles Bibliográficos
Autores principales: Califano, Daniela, Russo, Daniela, Scognamiglio, Giosuè, Losito, Nunzia Simona, Spina, Anna, Bello, Anna Maria, Capiluongo, Anna, Galdiero, Francesca, De Cecio, Rossella, Bevilacqua, Simona, Gargiulo, Piera, Marchesi, Edoardo, Canevari, Silvana, Perrone, Francesco, Daniele, Gennaro, De Cecco, Loris, Mezzanzanica, Delia, Pignata, Sandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226822/
https://www.ncbi.nlm.nih.gov/pubmed/32272732
http://dx.doi.org/10.3390/cells9040903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226822/
https://www.ncbi.nlm.nih.gov/pubmed/32272732
http://dx.doi.org/10.3390/cells9040903

Ejemplares similares